General Anesthetics Flashcards

1
Q

how might anesthetics interfere with CNS function

A

altering communication between neurons. Inhibiting excitatory synaptic transmission or enhancing inhibitory transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pre-synaptic effects of anesthetics

A

volatile anesthetics have been shown to decrease glutamate release and increase/decrease GABA release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

post-synaptic effects of anesthetics

A
  1. inhibit NMDA receptors (glutamate)
  2. increase frequency or length of time the Cl- channel remains open (GABA)
  3. increase affinity of receptor for glycine (glycine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

meyer-overton rule

A

potency of anesthetic gases directly related to their solubility in olive oil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

unitary theory of anesthesia

A

since variety of structurally unrelated drugs obey the rule, they must bind at same hydrophobic site. anesthetics likely bind to hydrophobic pockets on proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

physical characteristics of inhaled anesthetics

A

inorganic gas (N2O), volatile liquids (the fluranes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

desflurane vaporizer

A

desflurane boils at room temperature. dual gas blender. anesthesiologist controls vapor output into circuit by adjusting resistor. vapor is blended with fresh gas flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

inhaled anesthetics uptake and distribution

A

absorbed from alveoli into pulmonary capillary blood. distributed to site of action (brain) and to reservoirs. variably metabolized, eliminated principally via lungs. partial pressure gradients propel anesthetic to the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2nd gas effect

A

ability of high volume uptake of one gas to accelerate the rate of increase in Pa of a second gas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Guedel’s 4 stages of CNS depression

A
  1. analgesia -> analgesia + amnesia
  2. excitement/delirium (increased HR, RR, BP)
  3. surgical anesthesia
  4. medullary depression; without support of respiration and circulation, death ensues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which inhaled drugs increase heart rate?

A

isoflurane and desflurane (likely due to pungency stimulating airway receptors and eliciting reflex tachycardia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CNS effects of volatile agents

A

dose dependent depression of EEG, sensory evoked potentials, motor evoked potentials, cerebral metabolic rate. Increase in cerebral blood flod, increase in ICP which parallels cerebral blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cardiovascular effects of volatile agents

A

decrease in vascular resistance and arterial blood pressure. more blood flow to brain, muscle, and skin, less to liver, kidneys, and gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

respiratory effects of volatile agents

A

decrease in tidal volume, ventilatory response to hypoxia and hypercarbia. increase in respiratory rate. relaxation of airway smooth muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

neuromuscular function of volatile agents

A

directly relax skeletal muscle. potentiate the effects of neuromuscular blockers. trigger malignant hyperthermia in susceptible patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

barbituates

A

produce hypnosis/sedation only! produce hypnosis by enhancing actions of inhibitory neurotransmitters. Bind to GABAa to enhance Cl- conductance. Inhibit actions of glutamate by blocking NMDA receptors.

17
Q

what do barbituates and propofol produce?

A

dose dependent decreases in blood pressure due to vasodilation. dose dependent respiratory depression. barbituates are negative inotropes

18
Q

propofol

A

hypnosis through GABAa Cl current enhancing. Inhibits NMDA glutamate receptors. Depresses spinal cord neurons via action at GABAa and glycine receptors. stored in soybean oil/glycerol/egg (watch allergies). anti-emetic at low doses.

19
Q

propofol infusion syndrome

A

observed in critically ill patients receiving high dose infusions for more than 48 hours. associated with administration of catecholamines and glucocorticoids in these patients. metabolic acidosis, myocardial failure, rhabdo, hyperkalemia, renal failure.

20
Q

etomidate

A

only d-isomer that has anesthetic activity. associated with pain on induction due to propylene glycol solvent. subcortical disinhibition leads to involuntary myoclonic movements. high incidence of N/V post op. single dose inhibits cortisol synth. minimal cardiorespiratory depression! GABAa receptor agonist. NO ANALGESIC ACTIVITY!

21
Q

ketamine

A

dose related unconsciousness, amnesia, and analgesia. patients appear to be in cataleptic state. nystagmus, lacrimation, salivation. eyes remain open. CNS site of action may be thalamoneocortical projection system. depresses neuronal function and stimulates limbic system. NMDA receptor antagonist.

22
Q

ketamine cardiovascular effects

A

directly stimulates sympathetic nervous system. Increases systemic and pulmonary vascular resistance. Increases heart rate. increases cardiac work and O2 consumption (dont use in ppl with coronary artery disease). increases cerebral blood flow and intracranial pressure

23
Q

ketamine respiratory effects

A

bronchodilator. used as induction agent in patients with reactive airway disease, hypovolemia, heart things.

24
Q

unique uses of ketamine

A

useful sedative for pediatric patients. combined with propofol for IV procedural sedation. used as adjuvant to general anesthesia to decrease opioid use. Post op use to decrease opioid use. can be used in chronic pain management.

25
Q

dexmedetomidine

A

approved for sedation less than 24 hours in ventilated ICU patients. binds alpha 2A and 2B receptors in locuse caeruleus and spinal cord to produce sedation, sympatholysis, and anlgesia. easy to wake up, similar to natural sleep. used for awake procedures in OR, used post op for bariatric surgery. limited respiratory depression

26
Q

what do neuromuscular blockers do?

A

interrupt transmission of nerve impulses at the neuromuscular junction thus preventing muscles from contracting. structurally related to ACh. positive charge attracts them to muscarinic and nicotinic ACh receptors.

27
Q

succinylcholine

A

depolarizing agent. stimulates and opens ion channels of all ACh receptors. muscle groups contract in disorganized fashion. rapid onset and short duration. used to facilitate intubation. terminated by diffusion away from NMJ, rapidly hydrolyzed.

28
Q

succinylcholine side effects

A

stimulation of all cholinergic autonomic receptors. cardiac dysrhythmias. hyperkalemia can be life threatening with pre-existing neuromuscular disease. increased intracocular pressure, intracranial pressure, intragastric pressure. myalgias, masseter spasm

29
Q

non-depolarizing agents

A

drug-receptor interaction blocks the receptor from binding ACh, thus preventing physiologic depolarization and muscle contraction. effect terminated by diffusion away from NMJ. neuromuscular blockade can be antagonized by administration of an anti-cholinesterase

30
Q

factors effecting reversal of neuromuscular blockade

A

depth of blockade, duration of action of non-depolarizer, choice and dose of anti-cholinesterase (edrophonium is fastest onset, neostigmine is more complete antagonism, pyridostigmine has longer duration)

31
Q

monitoring NMB: train of four

A

reduction in muscle response during elecctrical nerve stimulus reflects type and degree of blockade. non-depolarizing blockade has a TOF ration of less than 1, wait for 1-2 twitches prior to reversal. Depolarizing blockade has TOF ratio of 1

32
Q

two drugs used to reverse NMB

A

glycopyrrolate, atropine. block muscarinic effects by administering anti-muscarinic. glycopyrrolate preferred